IRG1/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth.

IRG1/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth. Am J Cancer Res. 2023; 13(3):1067-1081.

View in: PubMed